Contact lens (CL) complications is an umbrella term for corneal and conjunctival disorders caused or triggered by CL wear, ranging from asymptomatic minor findings to corneal ulcers. Contact lens intolerance refers to a state in which ocular surface disorders and subjective symptoms persist or recur chronically, making continued CL wear difficult.
CL wear is the greatest risk factor for infectious keratitis1), and in the United States it is estimated that approximately 71,000 cases of microbial keratitis occur annually1). Among CL wearers overall, the annual incidence of CL-related corneal infiltrative events (CIE) has been reported as approximately 3-6 per 100 person-years5).
The main mechanisms by which CLs induce ocular disorders are broadly divided into the following 5.
With the widespread use of silicone hydrogel (SiHy) lenses, hypoxia-related complications have decreased, but intolerance due to lipid deposits has been on the rise6). CL wear is one of the greatest risk factors for Acanthamoeba keratitis (AK), and it has been reported that more than 88% of AK patients were CL wearers3). Daily disposable (DD) lenses substantially reduce AK risk compared with DW reusable lenses (OR 0.26; approximately a 3.84-fold difference), and it is estimated that switching to DD could prevent 30–62% of AK cases3).
QAre daily disposable lenses less likely to cause intolerance?
A
Daily disposable lenses require no lens care, carry no risk of case contamination, and minimize the accumulation of protein deposits. They make giant papillary conjunctivitis and care-solution-related complications less likely, and they also substantially reduce the risk of Acanthamoeba keratitis. However, dry-eye-related epithelial damage and complications from overnight wear can still occur even with daily disposable lenses, so managing wearing time and having regular examinations remain important.
Iceclanl. Contact Lens Related Small Corneal Ulcer with Sodium Fluorescein Staining. Wikimedia Commons. 2015. Figure 1. Source ID: commons:File:Contact_Lens_Related_Small_Corneal_Ulcer_with_Sodium_Fluorescein_Staining_1.jpg. License: CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/).
The slit-lamp photograph shows a small corneal ulcer associated with contact lens wear after sodium fluorescein staining. The epithelial defect is clearly visible as yellow-green fluorescence on the corneal surface.
May be noticed along with worsening wearing comfort
Shortened wearing time
Wanting to remove CLs earlier than before
If hyperemia, eye discharge, and pain all occur together, there is a possibility of infectious corneal ulcer, and particular caution is required. Even acute epithelial edema can cause marked visual impairment and eye pain, so do not determine infectious versus non-infectious based on symptoms alone. All CLs reduce corneal sensation (hypoesthesia). Because of reduced sensation, CL wearers may have difficulty noticing the early symptoms of corneal damage1).
When fluorescein staining findings are classified by pattern according to the way they spread (punctate, areal, linear) and depth (SPK, corneal erosion, corneal ulcer), the cause is easier to infer.
Location: Confined to the 3 o’clock and 9 o’clock directions of the corneal limbus
Cause: During blinking, the HCL moves up and down about 2 mm, and when it draws in tears from the 3 o’clock and 9 o’clock directions, localized dryness occurs. It also appears with steep fitting.
Course: Mild cases heal in 3–5 days. If it progresses to erosion, about 1 week is required, and corneal opacity may remain
Smile mark punctate superficial keratitis (SCL)
Location: Below the pupillary area (matching the shape of a smiling mouth)
Cause: Occurs in patients who originally have dry eye when the tear fluid under the lens decreases. It is a pattern specific to dry eye in SCL wearers.
Course: Manage with eye drops for dry eye. Instruct early removal from the evening onward
Diffuse punctate superficial keratitis (HCL/SCL)
Location: Almost uniform across the entire cornea
Cause: Oxygen deficiency due to CL wear. Lens deposits add mechanical irritation and worsen the condition.
Course: Heals in 4–5 days with discontinuation of CL wear and eye drop treatment.
Other punctate lesion patterns are as follows.
Pattern
Cause
Features
Donut-shaped punctate superficial keratitis
Pigment exposure from color CL, SiHy + PHMB
Sparse in the center, concentrated in the periphery
Big-mouth punctate superficial keratitis
Oxygen deficiency from prism-ballast SCL
Localized to the lower 2/3 of the cornea
Ring-shaped staining
Incompatibility between SiHy and care solution
Became a problem around 2010, now markedly decreased
The following are important as patchy and linear lesions.
SEAL (superior epithelial arcuate lesion): When wearing SCLs made of hard SiHy material, an arcuate corneal epithelial lesion parallel to the limbus occurs in the peripheral cornea at the 11 o’clock to 1 o’clock direction. It is caused by mechanical damage resulting from the upper eyelid pressing on the relatively hard SiHy lens.
Corneal infiltrates (CLPU, CLARE): Non-infectious immune-mediated infiltrates caused by an immune response to bacterial products6). Single, small, peripheral lesions are characteristic of CLPU. Multiple lesions are characteristic of CLARE.
Infectious corneal ulcer: Characterized by the triad of hyperemia, ocular discharge, and pain1). Emergency management is required.
Giant papillary conjunctivitis (GPC): Giant papillae are observed on eversion of the upper eyelid. It is seen not only with conventional SCLs but also with silicone hydrogel lenses.
Peripheral corneal infiltrates: Inflammatory cells infiltrate epithelial damage associated with foreign bodies under the lens.
Limbal corneal infiltration: Appears as multiple lesions along the corneal limbus, associated with biofilm contamination of lens cases and pigment exposure from colored CLs.
Acute epithelial edema: Epithelial edema of the entire cornea, especially the central portion, also called overwear syndrome.
Corneal erosion: Punctate superficial keratopathy may progress to full-thickness epithelial loss.
Findings with stuck HCL: Lens edge indentation and pseudodendritic keratitis may occur.
QWhat should be done if pain occurs while wearing contact lenses?
A
First, remove the CL immediately. If the pain is mild and there is no vision loss, it is possible to stop wearing them until the next day and observe. However, if redness, eye discharge, or severe pain is present, infectious keratitis is possible, so promptly visit an ophthalmologist. Do not discard the removed CL; it is advisable to bring it to the visit for investigation of the cause.
Pay attention to contamination of the lens case, overnight wear, and epithelial damage caused by care solutions. Lens cases not replaced for 3 months or longer develop biofilm, which can cause peripheral corneal infiltrates. Forgetting to neutralize the disinfectant can cause mild chemical injury. There is also allergic corneal epithelial damage caused by MPS.
The characteristics and precautions of the main CL care solutions are shown below.
Type
Characteristics
Precautions
MPS/MPDS
Can clean, disinfect, and store in one solution
Weak disinfecting effect against fungi and viruses
Hydrogen peroxide solution
Stronger disinfecting effect than MPS
Possible keratoconjunctival damage if neutralization is inadequate
Povidone-iodine solution
Strongest disinfecting effect
Cannot be used in iodine allergy
No matter how strong the disinfecting effect is, neglecting basic care such as rubbing and rinsing, and cleaning and drying the lens case, can cause serious ocular disorders such as corneal ulcer7).
For the diagnosis of CL intolerance, a detailed interview about the CL type, lens care method, and wearing time is essential. Slit-lamp microscopy is essential for diagnosing CL-related corneal disorders, and fluorescein staining is useful for determining the pattern of epithelial defects. In eyes wearing HCLs, a key point is to observe the lens surface for dirt and wettability before fluorescein staining.
As the lens surface dries, dirt becomes more visible, so surface observation with a slit lamp is also performed. Acute epithelial edema may appear as a full-thickness epithelial defect. Even without an epithelial defect, fluorescein may penetrate due to weakening of tight junctions, and about 10 minutes after staining the entire cornea may appear stained.
Estimate the cause from the staining site, morphology, and extent.
For staining in the upper cornea, consider SEALs, superior limbic keratoconjunctivitis, and allergic keratoconjunctivitis; for central to lower staining, consider dry eye, smile mark punctate superficial keratopathy, and diabetic keratopathy; for lower staining, consider incomplete blinking and meibomian gland dysfunction; and for staining of the entire cornea, consider drug toxicity, severe dry eye, and overnight lens wear in the differential diagnosis.
In differentiating infectious from non-infectious causes, the triad of hyperemia, ocular discharge, and pain, along with the presence or absence of anterior chamber inflammation, is important. CLPU may occur without an epithelial defect, so care must be taken to distinguish it from infectious keratitis6).
In differentiating SEALs from superior limbic keratoconjunctivitis, the latter also stains the conjunctival epithelium. Pseudodendritic keratitis associated with stuck HCL resembles the dendritic ulcer of herpes simplex keratitis in that the ends of the linear lesion branch into two or more.
The prognosis of CL intolerance varies depending on the cause and severity. In mild superficial punctate keratitis (SPK), the epithelium recovers within 3–5 days after discontinuing CL use, and complete healing can be expected with the addition of eye drop treatment. SEALs and 3 o’clock/9 o’clock staining erosions require about 7–10 days and may leave opacities.
If infectious keratitis becomes severe, antibacterial treatment and inpatient management may be necessary, and corneal scarring or irregular astigmatism may remain after healing. Acanthamoeba keratitis may require more than a year of treatment, and some severe cases require corneal transplantation.
The prognosis of non-infectious corneal infiltrates (CLPU/CLARE) is generally good, and with appropriate management they usually heal within 1–2 weeks9). However, if recurrence is repeated, the approach to CL wear must be fundamentally reconsidered. In cases with frequent recurrence, a comprehensive approach combining a change to DD lenses, changes in the wearing schedule, strengthened dry eye treatment, and MGD management is required.
The prognosis of giant papillary conjunctivitis (GPC) is good with appropriate treatment and elimination of the cause (protein deposits, CL material), but recurrence is likely if the CL type is not changed. Improvement of GPC may take several weeks to several months. In refractory cases with repeated GPC flare-ups, complete transition to glasses or transition to refractive surgery such as ICL, LASIK, or SMILE may also be considered as long-term options.
Discontinuation of CL wear and removal of the cause are fundamental. The cause is inferred from the corneal findings, and the healing period, presence or absence of sequelae, and need for CL change are explained individually.
Punctate superficial keratitis may take 3–5 days with CL discontinuation and eye drop treatment, while corneal erosion may require about 1 week for epithelial repair even with antibacterial and sodium hyaluronate eye drops, and opacity may remain. In refractory punctate superficial keratitis, tear break-up may be involved. In CL-related corneal abrasion, the use of eye patches or therapeutic CLs is not recommended due to the risk of secondary infection1).
After healing, CL changes are made according to the cause. For 3 o’clock and 9 o’clock staining, changing to SCL is effective; for SEALs, selecting a safe SCL is effective; and for smile-mark punctate superficial keratitis, changing to a silicone hydrogel lens with excellent water retention is effective.
Eye drop treatment:
For dry eye-related cases: 3% diquafosol sodium ophthalmic solution 6 times daily or 2% rebamipide ophthalmic solution UD 4 times daily
Epithelial repair support: 0.1% or 0.3% sodium hyaluronate ophthalmic solution 4–6 times daily
When inflammation is severe (after excluding infection): 0.1% fluorometholone ophthalmic solution 4 times daily
Treatment consists of discontinuing CL wear and using antibacterial agents plus low-concentration steroids (0.1% fluorometholone) eye drops. Because infiltrative lesions may remain as opacities, steroid use is desirable, but use should be carefully judged at a stage when infection cannot be completely ruled out. The Guidelines for the Management of Infectious Keratitis (3rd edition) state that concomitant steroid eye drops for bacterial keratitis are “weakly recommended against”8), and easy use before identification of the causative organism should be avoided.
In sterile infiltrates after infection has been excluded, if poor compliance with steroid eye drops is anticipated, there is also the option of observing the course with NSAID eye drops. This option should not be applied to cases in which infection is suspected.
Indication: Small non-central ulcers with infiltration of 2 mm or less and located 3 mm or more from the visual axis
Treatment: Empirical therapy with fluoroquinolone eye drops (empiric therapy). 0.5% levofloxacin, 0.5% moxifloxacin, etc., 4 to 6 times daily
Vision threat present
Indication: Infiltration greater than 2 mm, less than 3 mm from the visual axis, or worsening 48 hours after starting treatment
Treatment: Perform corneal culture + Gram staining, and start vancomycin (25-50 mg/mL) + fortified tobramycin (14 mg/mL) eye drops hourly. Change drugs according to culture results1)
Immediate discontinuation of CL is essential. Causative organisms of microbial keratitis include Pseudomonas aeruginosa, staphylococci, streptococci, and Serratia. For Acanthamoeba keratitis, multidrug combination therapy such as polyhexamethylene biguanide (PHMB) and propamidine isethionate is used.
The basis is discontinuing CL wear or switching to a daily disposable type. Use 0.1% fluorometholone 4 times daily for 1–2 weeks. Even after symptoms improve, returning to the original lens often causes recurrence, so changing the CL type is desirable.
When BCL is used for pain relief in microcystic or bullous corneal epitheliopathy, a thin lens with high water content and high Dk value is considered safe2). During use, concomitant prophylactic broad-spectrum antibiotics are recommended to prevent secondary infection2). BCL does not serve as a long-term solution for corneal edema2).
QAre silicone hydrogel lenses safe?
A
Silicone hydrogel lenses have dramatically improved oxygen permeability compared with conventional HEMA lenses, and hypoxia-related complications have decreased substantially. However, because the material is hydrophobic, it tends to attract lipid deposits, making appropriate selection of care products important. Due to the hardness of the material, SEALs can occur, and ring-shaped staining has been reported with incompatibility with some care products. Whichever CL is used, proper care and regular examinations are essential.
CLs restrict the supply of atmospheric oxygen to the cornea. With lenses of low oxygen transmissibility (Dk/t), anaerobic metabolism in the corneal epithelium increases, and epithelial edema arises from osmotic elevation due to lactate accumulation. In the era of PMMA lenses, central corneal epithelial edema called central circular clouding was seen. With conventional HEMA SCLs, which were mainstream until around 1990, acute epithelial edema due to oxygen deficiency occurred frequently, but now that SiHy lenses have become mainstream, hypoxic damage has decreased. Chronic hypoxia induces corneal neovascularization, and in long-term wearers this may reflect latent limbal stem cell deficiency.
Friction between the CL and the ocular surface during blinking causes epithelial damage. HCLs move about 2 mm up and down with each blink, and tear fluid becomes depleted at the 3 o’clock and 9 o’clock positions, leading to punctate superficial keratopathy. If irritation from the lens edge is added, this can progress to corneal erosion or infiltration. With SCLs, lid-wiper epitheliopathy (LWE) and SEALs can occur due to friction with the upper eyelid.
Friction between the CL and the ocular surface during blinking causes epithelial damage. With HCLs, the lens moves about 2 mm up and down with each blink, and as tear fluid is drawn in from the 3 o’clock and 9 o’clock positions, local dryness and punctate superficial keratopathy occur. With SCLs, SEALs develop at the site where the upper eyelid presses on the CL, and are especially likely to occur when the corneal-side surface of the lens is irregular.
Because the material of SiHy lenses is hydrophobic, the surface is modified to be hydrophilic by plasma treatment or similar. Unlike conventional hydrogel lenses, they are prone to lipid deposits, and the cleaning agents contained in MPS also need to address lipid deposits. When lipid deposits accumulate, they provoke an immune response and cause GPC and corneal infiltration6).
In giant papillary conjunctivitis, in addition to a type I allergic reaction to proteins deposited on the CL surface, constant contact and irritation of the upper palpebral conjunctiva by the lens leads to inflammation and the formation of giant papillae.
Chronic mechanical irritation from CL wear and bacterial endotoxins provoke an immune response, producing sterile infiltration9). This is often caused by inadequately disinfected SCLs or biofilm inside the lens case10). Biofilm formation inside the lens case is an important risk factor for infectious keratitis, and bacteria within biofilm are highly resistant to disinfectants10). In GPC, a type I allergic reaction to proteins deposited on the CL surface is involved.
AK is a severe protozoal keratitis unique to CL wearers. Acanthamoeba is widely present in tap water, pools, soil, and similar environments, and invades the cornea of CL wearers. Microdamage to the corneal epithelium caused by CLs serves as the portal of entry for AK. Pain is severe (especially worsening at night), and radial keratoneuritis along the corneal nerves is an early sign of AK. Treatment requires combination therapy with multiple agents such as PHMB and propamidine isethionate, and some severe cases require long-term treatment (1 year or more).
Multifocal soft contact lenses are sometimes used for the purpose of controlling myopia progression. Multiple RCTs with Level I evidence have shown significant control of myopia progression compared with single-vision lenses or spectacles, with reported SE change of -0.22 to -0.81 D in the multifocal CL group and -0.50 to -1.45 D in the control group4). No serious adverse events have been reported, but the long-term effects, optimal treatment duration, and rebound effect after discontinuation of wear have not been established4). When using multifocal CLs in children with CL intolerance, it is necessary to carefully evaluate the balance between management of CL intolerance and the myopia control effect.
Public health strategies for preventing Acanthamoeba keratitis
Reducing AK risk by switching to DD lenses has great public health significance. It has been estimated that 30-62% of AK cases could be prevented by transitioning from DW reusable lenses to DD lenses3), and a review of prescribing policies together with patient education is required.
TFOS CLEAR (Contact Lens Evidence-Based Academic Reports), published in 2021, systematized the classification, epidemiology, risk factors, and preventive measures for CL complications6), and has become an international standard reference for inflammatory complications including CL intolerance. It emphasizes the importance of risk stratification and individualized management based on the combination of lens material, wearing schedule, and care products6).
Staphylococcus aureus readily colonizes the CL surface and lens case, and is one of the major causative organisms of CLPU and CLARE. In the study by Jalbert et al., Staphylococcus aureus was isolated from the CL surface at the onset of CLPU, and bacterial components (peptidoglycan and lipoteichoic acid) were shown to trigger immune responses via Toll-like receptors on the corneal epithelium11). With continuous wear (30 days) of SiHy lenses, the annual incidence of non-infectious corneal infiltrates reaches approximately 20 events per 100 patient-years, and although hypoxia-related complications have decreased, the risk of CIE remains high12).
According to the latest review by Steele et al., the epidemiology of CL-related infiltrative events varies greatly depending on material, wearing schedule, and care13). DD lenses significantly reduce CIE risk and are one of the important preventive strategies in the management of CL intolerance.
Relationship between dry eye treatment and CL intolerance
Stepwise dry eye treatment based on TFOS DEWS III may lead to improved prognosis for CL intolerance in general by correcting the dry eye that underlies CL-related ocular surface disorders, including CLIDE14). Tear secretion-promoting drugs such as artificial tears, diquafosol, and rebamipide may improve CLIDE symptoms and increase the rate of continued CL wear.
The number of contact lens (CL) wearers worldwide has reached approximately 300 million, and preventing CL-related complications is an important public health issue15). Through the prevention and management of CL intolerance, maintaining CL wearers’ QOL and ocular health over the long term is an important role of ophthalmologists.
Regular lens case replacement and biofilm prevention
There are reports that bacterial contamination is found in 30-80% of lens cases in use10), making rubbing and rinsing, regular case replacement, and drying essential. Regular cleaning (about once every 2 weeks) with a sodium hypochlorite preparation (such as Progent) has been reported to be effective for biofilm removal, and it is also recommended in orthokeratology guidelines.
American Academy of Ophthalmology. Bacterial Keratitis Preferred Practice Pattern. Ophthalmology. 2024;131(2):P265-P330.
American Academy of Ophthalmology. Corneal Edema and Opacification Preferred Practice Pattern. Ophthalmology. 2024.
Carnt N, Minassian DC, Dart JKG. Acanthamoeba Keratitis Risk Factors for Daily Wear Contact Lens Users: A Case-Control Study. Ophthalmology. 2023;130(1):48-55. doi:10.1016/j.ophtha.2022.08.002. PMID:35952937.
Cavuoto KM, Trivedi RH, Prakalapakorn SG, Oatts JT, Nallasamy S, Morrison DG, Pineles SL, Chang MY. Multifocal Soft Contact Lenses for the Treatment of Myopia Progression in Children: A Report by the American Academy of Ophthalmology. Ophthalmology. 2025;132(4):495-503. doi:10.1016/j.ophtha.2024.09.031. PMID:39503665; PMCID:PMC11930616.
Stapleton F, Keay L, Edwards K, Naduvilath T, Dart JK, Brian G, et al. The incidence of contact lens-related microbial keratitis in Australia. Ophthalmology. 2008;115(10):1655-62. doi:10.1016/j.ophtha.2008.04.002. PMID:18538404.
Stapleton F, Bakkar M, Carnt N, Chalmers R, Vijay AK, Marasini S, et al. CLEAR - Contact lens complications. Contact lens & anterior eye : the journal of the British Contact Lens Association. 2021;44(2):330-367. doi:10.1016/j.clae.2021.02.010. PMID:33775382.
Sweeney DF, Jalbert I, Covey M, Sankaridurg PR, Vajdic C, Holden BA, et al. Clinical characterization of corneal infiltrative events observed with soft contact lens wear. Cornea. 2003;22(5):435-42. doi:10.1097/00003226-200307000-00009. PMID:12827049.
Wu YT, Willcox M, Zhu H, Stapleton F. Contact lens hygiene compliance and lens case contamination: A review. Contact lens & anterior eye : the journal of the British Contact Lens Association. 2015;38(5):307-16. doi:10.1016/j.clae.2015.04.007. PMID:25980811.
Jalbert I, Willcox MD, Sweeney DF. Isolation of Staphylococcus aureus from a contact lens at the time of a contact lens-induced peripheral ulcer: case report. Cornea. 2000;19(1):116-20. doi:10.1097/00003226-200001000-00023. PMID:10632021.
Loretta Szczotka‐Flynn, Mireya Diaz. Risk of Corneal Inflammatory Events with Silicone Hydrogel and Low Dk Hydrogel Extended Contact Lens Wear: A Meta‐Analysis. OVS. 2007;84(4):247-256. doi:10.1097/opx.0b013e3180421c47.
Steele KR, Szczotka-Flynn L. Epidemiology of contact lens-induced infiltrates: an updated review. Clinical & experimental optometry. 2017;100(5):473-481. doi:10.1111/cxo.12598. PMID:28868803.
Jones L, Craig JP, Markoulli M, Karpecki P, Akpek EK, Basu S, et al. TFOS DEWS III: Management and Therapy. American journal of ophthalmology. 2025;279:289-386. doi:10.1016/j.ajo.2025.05.039. PMID:40467022.
Craig JP, Alves M, Wolffsohn JS, Downie LE, Efron N, Galor A, et al. TFOS Lifestyle Report Executive Summary: A Lifestyle Epidemic - Ocular Surface Disease. The ocular surface. 2023;30:240-253. doi:10.1016/j.jtos.2023.08.009. PMID:37659474.
Copy the article text and paste it into your preferred AI assistant.
Article copied to clipboard
Open an AI assistant below and paste the copied text into the chat box.